Neuphoria Therapeutics Inc. (NEUP) - AdvisorShares Trust filed SCHEDULE 13G
- AdvisorShares Trust owns 5.78% of Neuphoria Therapeutics Inc.
- 312,895 shares beneficially owned by AdvisorShares Trust.
- Filing date: 2026-10-05.
AdvisorShares Trust
Every EDGAR filing for Neuphoria Therapeutics Inc. (NEUP), newest first, with AI summaries and stories.
Next: 10-Q expected ~Nov 16 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
AdvisorShares Trust
Ownership stake disclosure by Coastlands Capital LP (amended)
Coastlands Capital LP, filed by
Ownership stake disclosure by Baselake Partners, LP (amended)
Baselake Partners, LP, filed by
Peter Miles Winston Davies, insider filing for NEUP
Peter Miles Winston Davies, reporting
Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Lynx1 Capital Management LP, filed by
Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
Ownership stake disclosure by Coastlands Capital LP
Coastlands Capital LP, filed by
Ownership stake disclosure by Baselake Partners, LP
Baselake Partners, LP, filed by